Hydrocodone Extended-Release Tablets and Insulin degludec and liraglutide Subcutaneous
Determining the interaction of Hydrocodone Extended-Release Tablets and Insulin degludec and liraglutide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hydrocodone
Brand name: Hysingla ER, Zohydro ER, Vantrela ER
Synonyms: Hydrocodone
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hydrocodone Extended-Release Tablets-Insulin degludec Subcutaneous
- Hydrocodone Extended-Release Tablets-Insulin detemir
- Hydrocodone Extended-Release Tablets-Insulin Detemir (Cartridges and Prefilled Syringes)
- Hydrocodone Extended-Release Tablets-Insulin Detemir (Vials)
- Hydrocodone Extended-Release Tablets-Insulin detemir Subcutaneous
- Hydrocodone Extended-Release Tablets-Insulin glargine
- Insulin degludec and liraglutide Subcutaneous-Hydrocodone Polistirex and Chlorpheniramine Polistirex Suspension
- Insulin degludec and liraglutide Subcutaneous-Hydrocodone, Chlorpheniramine, and Pseudoephedrine
- Insulin degludec and liraglutide Subcutaneous-Hydrocodone, Pseudoephedrine, and Guaifenesin
- Insulin degludec and liraglutide Subcutaneous-Hydrocortisone
- Insulin degludec and liraglutide Subcutaneous-Hydrocortisone (Systemic)
- Insulin degludec and liraglutide Subcutaneous-Hydrocortisone 2.5%